Kiniksa Pharmaceuticals International, plc Defined Contribution Plan, Cost
Kiniksa Pharmaceuticals International, plc (KNSA) reported Defined Contribution Plan, Cost of $2.31 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2024-02-28
- Kiniksa Pharmaceuticals International, plc defined contribution plan, cost for fiscal 2023 was $2.31M, a 36.96% increase from fiscal 2022.
- Kiniksa Pharmaceuticals International, plc defined contribution plan, cost for fiscal 2022 was $1.68M, a 8.02% increase from fiscal 2021.
- Kiniksa Pharmaceuticals International, plc defined contribution plan, cost for fiscal 2021 was $1.56M, a 56.90% increase from fiscal 2020.
- Kiniksa Pharmaceuticals International, plc defined contribution plan, cost for fiscal 2020 was $993.00K, a 16.69% increase from fiscal 2019.
| Period end | Defined Contribution Plan, Cost 12 month |
|---|---|
| 2023-12-31 | $2.31M 10-K · filed 2024-02-28 |
| 2022-12-31 | $1.68M 10-K · filed 2024-02-28 |
| 2021-12-31 | $1.56M 10-K · filed 2024-02-28 |
| 2020-12-31 | $993.00K 10-K · filed 2023-03-02 |
| 2019-12-31 | $851.00K 10-K · filed 2022-02-24 |
| 2018-12-31 | $315.00K 10-K · filed 2021-02-25 |
| 2017-12-31 | $264.00K 10-K · filed 2019-03-12 |